Original paper

Androgen content and BET bromodomain proteins influence enzalutamide agonism of mutant F876L androgen receptor.

Volume: 34, Issue: 15_suppl, Pages: e16538 - e16538
Published: May 20, 2016
Abstract
e16538 Background: One emergent resistance mechanism to medical castration is intratumoral androgen synthesis that activates the androgen receptor (AR). This insight led to the development of the AR antagonist enzalutamide. One enzalutamide resistance mechanism is AR F876L mutations that lead to enzalutamide agonism in some cases. However, mechanisms that contribute to the agonist switch have not been fully clarified, and there are no therapies...
Paper Details
Title
Androgen content and BET bromodomain proteins influence enzalutamide agonism of mutant F876L androgen receptor.
Published Date
May 20, 2016
Volume
34
Issue
15_suppl
Pages
e16538 - e16538
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.